CDKN2A and diabetes mellitus: We assessed whether the protective effect of Tg3 mice in diabetes-induced VED is mediated by reducing expression of NFκB and COX2 (inflammatory markers) and levels of p16INK4A and cleaved caspase-3 (apoptotic markers).